Na<sup>+</sup>-Taurocholate Co-Transporting Polypeptide (NTCP) in Livers, Function, Expression Regulation, and Potential in Hepatitis B Treatment
Chronic hepatitis B virus (HBV) infection has become one of the leading causes of liver cirrhosis and hepatocellular carcinoma globally. The discovery of sodium taurocholate co-transporting polypeptide (NTCP), a solute carrier, as a key receptor for HBV and hepatitis D virus (HDV) has opened new ave...
Main Authors: | Xiaoyu Zhao, Waqas Iqbal, Pingnan Sun, Xiaoling Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Livers |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4389/1/4/19 |
Similar Items
-
Tyrosine 146 of the Human Na<sup>+</sup>/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes
by: Dariusz Zakrzewicz, et al.
Published: (2022-06-01) -
The Culprit Behind HBV-Infected Hepatocytes: NTCP
by: Li S, et al.
Published: (2024-10-01) -
Multitasking Na<sup>+</sup>/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery
by: Dariusz Zakrzewicz, et al.
Published: (2022-01-01) -
Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
by: Kento Fukano, et al.
Published: (2019-01-01) -
Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment
by: Yan Li, et al.
Published: (2022-04-01)